Situation normale

Inhatarget Therapeutics
 SRL

6041 Charleroi
Since 29/08/2019
BE0732994752
Financial Health Indicator
9
Equity
€3.0M
-23% YoY
Gross Operating Margin
€74.7K
-60% YoY
EBITDA
€-279.6K
-38% YoY
Gain/Loss
€-922.7K
+40% YoY
Employees
5
-7% YoY

Inhatarget Therapeutics’s business network visualized

Explore our interactive spiderweb to visually navigate Inhatarget Therapeutics’s entire network of mandates and participations. Get insights into both current and historical connections.

Spiderweb Inhatarget Therapeutics
Inhatarget Therapeutics
  • Mohamed Sebti
    1090 Jette
    Since 2020
  • Karim Amighi
    1150 Woluwe-Saint-Pierre/Sint-Pieters-Woluwe
    Since 2020

Detailed insights into Inhatarget Therapeutics’s financial history

See financial trends including, equity, operating income, profit/loss and employees of Inhatarget Therapeutics. Compare KPI’s against similar companies. Explore financial ratios, annual accounts and much more.

Financials 1
Financials 2
Financials 3
Financials 4
2023 2022 2021 2020
Equity
3.0M
3.8M
2.0M
3.1M
Gross Operating Margin
74.7K
186.6K
127.4K
-84.6K
Gain/Loss
-922.7K
-1.5M
-1.0M
-597.1K
Employees
5.5
5.9
3.4
2.8

Find similar companies like Inhatarget Therapeutics

Find more companies with similar activities to Inhatarget Therapeutics from our extensive database.

Frequently asked questions about Inhatarget Therapeutics

  • What is the email adress of Inhatarget Therapeutics?

    You can contact Inhatarget Therapeutics at the email address info@inhatarget.com.

  • Where is Inhatarget Therapeutics located?

    Inhatarget Therapeutics’s headquarters is located in Rue Antoine de Saint-Exupéry 2 , 6041 Charleroi.

  • Who are the directors of Inhatarget Therapeutics?

    Inhatarget Therapeutics’s directors include
    • Mohamed Sebti
    • Karim Amighi

  • When was Inhatarget Therapeutics founded?

    Inhatarget Therapeutics was founded in 2019-08-29. Inhatarget Therapeutics has been active for 6 years.

  • What are Inhatarget Therapeutics’s NACEBEL codes?

    Inhatarget Therapeutics’s NACEBEL codes are
    • 72101 Recherche-développement en biotechnologie (2025)
    • 72110 Recherche-développement en biotechnologie (2008)
    • 74909 Autres activités spécialisées, scientifiques et techniques (2008)

  • What is Inhatarget Therapeutics’s VAT number?

    Inhatarget Therapeutics’s VAT number is BE0732994752.

  • What is Inhatarget Therapeutics’s juridical form?

    Inhatarget Therapeutics’s juridical type is Société à responsabilité limitée (SRL).

  • How many employees does Inhatarget Therapeutics have?

    Inhatarget Therapeutics has 5 employees.

  • How is the financial situation of Inhatarget Therapeutics?

    openthebox has estimated that Inhatarget Therapeutics’s financial health score to be 9/10.